Supplementary Figure 4 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations

MLA

José Baselga, et al. Supplementary Figure 4 from NVP-BEZ235, a Dual PI3K/MTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations. Mar. 2023. EBSCOhost, https://doi.org/10.1158/0008-5472.22376271.

APA

José Baselga, Joaquin Arribas, Josep Lluis Parra, Carlos Garcia-Echeverria, Michel Maira, Serena Di Cosimo, Francesco Atzori, Elisabeth Llonch, Maria Luisa Botero, Marta Guzman, Vanesa Valero, Pieter J.A. Eichhorn, Maurizio Scaltriti, Ben Markman, & Violeta Serra. (2023). Supplementary Figure 4 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations. https://doi.org/10.1158/0008-5472.22376271

Chicago

José Baselga, Joaquin Arribas, Josep Lluis Parra, Carlos Garcia-Echeverria, Michel Maira, Serena Di Cosimo, Francesco Atzori, et al. 2023. “Supplementary Figure 4 from NVP-BEZ235, a Dual PI3K/MTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations,” March. doi:10.1158/0008-5472.22376271.